Pain and Anaesthesia Research Clinic (PARC)

The University of Adelaide Australia
You are here: 
text zoom : S | M | L
Printer Friendly Version
Further Enquiries
Melanie Gentgall
Clinical Research Manager
Pain and Anaesthesia Research Clinic
Royal Adelaide Hospital
North Terrace, Adelaide
South Australia 5000
Email

Telephone: +61 8 8222 2712
Facsimile: +61 8 8222 2713

Affiliated Services

Clinical Laboratory Services

  • The adjacent Institute of Medical and Veterinary Science (IMVS) is able to perform both the routine screening tests as well as the more unusual tests, with a rapid turn around time for standard laboratory tests and urine and serum drug screening. Laboratories are fully accredited.

Monitored alarmed facilities

  • Storing samples in monitored alarmed facilities is outsourced to the IMVS.

Pharmacogenetics

  • Screening for relatively routine assays such as those for cytochrome P450 polymorphism are performed at the IMVS. Specialised pharmacogenetic assays eg. for drug transporters is performed in the Pharmacology Discipline at the University of Adelaide

Bioanalysis

  • There is a range of laboratories able to undertake bioanalysis in Adelaide. We have staff trained in IATA 650 regulations who are experienced with sample preparation and shipment.

Trial Monitoring

  • We have good relationships with both large international companies and small local monitoring organisations.

Statistics and Data Management

  • We work with a range of outsourcing providers for statistics and data management.

Pharmacokinetic data analysis

  • PK/PD analysis and population pharmacokinetics analysis are performed with the assistance of Dr Richard Upton of the Department of Anaesthesia of the Royal Adelaide Hospital.

Consulting

  • PARC principals and affiliates are available for consulting on the interpretation of pre-clinical data, the need for additional pre-clinical data, the adequacy of data for a regulatory package and advice on design and interpretation of studies. PARC principals are members of Scientific Advisory Boards of local and overseas pharmaceutical companies. They are also available for assessment of project feasibility and technical due diligence.
  • We can provide input into study design both as a single centre for proof of concept trials and also as a participating centre in later phase multicenter trials.

Facilities

  • In addition to executing studies ourselves the PARC clinical facility can also be made available to other local investigators planning to undertake specialised studies.